Pharmanoble Chem Limited, a active public limited company, was established on 14 August 2020 in Hyderabad, Telangana, India. Engaging in industrial chemicals within the chemicals and materials sector, it holds CIN: U24233TG2020PLC142836. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Mohammed Abrar (Additional Director), Naziya Sultana (Director), Sumaira Sultana (Director). Past directors included Omer Mohammed. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 17-8-187, Noble Residency, First Floor Chowni Chanchalguda, Hyderabad, Telangana, 500023.
U24233TG2020PLC142836
142836
14 August 2020
₹1.00 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Pharmanoble Chem Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mohammed Abrar | Additional Director | 15 Feb 2024 | Current |
| Naziya Sultana | Director | 14 Aug 2020 | Current |
| Sumaira Sultana | Director | 14 Aug 2020 | Current |
| Akthar Mohammed | Director | 14 Aug 2020 | Current |
| Rauf Qadri Syed | Director | 14 Aug 2020 | Current |
| Akram Mohd | Director | 14 Aug 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Dec 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Pharmanoble Chem Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Pharmanoble Chem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Pharmanoble Chem has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Pharmanoble Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmanoble Chem's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Pharmanoble Chem Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Pharmanoble Chem Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
Mohammed Abrar was appointed as a Additional Director was appointed as a Additional Director on 15 Feb 2024 & has been associated with this company since 1 year 10 months . was recorded as a recent event.
Progress on Naziya Sultana was appointed as a Director was appointed as a Director on 14 Aug 2020 & has been associated with this company since 5 years 4 months . was documented.
Sumaira Sultana was appointed as a Director was appointed as a Director on 14 Aug 2020 & has been associated with this company since 5 years 4 months . was recorded as a recent event.
Akthar Mohammed was appointed as a Director was appointed as a Director on 14 Aug 2020 & has been associated with this company since 5 years 4 months . was recorded as a recent event.
The CIN of Pharmanoble Chem Limited is U24233TG2020PLC142836.
Pharmanoble Chem Limited is headquartered at 17-8-187, Noble Residency, First Floor Chowni Chanchalguda, Hyderabad, Telangana, 500023.
Pharmanoble Chem Limited was incorporated on 14 August 2020.
The current directors of Pharmanoble Chem Limited are
The primary industry of Pharmanoble Chem Limited is Chemicals And Materials.
Pharmanoble Chem Limited is unlisted.
The authorized capital of Pharmanoble Chem Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX